摘要
目的:针对支气管哮喘缓解期,采用文献学方法,筛选评价中医药治疗的适宜性技术,以期指导临床医师使用。方法:检索中国知网数据库、维普期刊资源整合服务平台、万方数据库、中国生物医学文献服务系统的期刊文献,纳入所有中医药治疗支气管哮喘缓解期的临床研究。基于中医农村适宜技术筛选评价指标体系,提取评估指标并进行评价。结果:共筛选得到150个治疗技术,主要为中药复方和穴位贴敷组成。评分分布在24.857至34.304之间,筛选评分最高的为治疗哮喘缓解期肺肾两虚的补肺颗粒。结论:初步筛选补肺颗粒、玉屏风散、邵氏阳虚哮喘贴等20项中医药治疗哮喘缓解期的适宜技术,可在基层推广应用。
To screen and evaluate the TCM in the treatment of bronchial asthma. Methods Retrieved the journals from China National Knowledge Infrastructure, the Vip Database, Wanfang Data and the Chinese Biomedical Literature Database(Sino Med). The time limitation ran from January 1, 1987 to December 31, 2016. Extracted the indicators of the assessment based on the evaluating and screening system of country feasible TCM technology. Results a total of 150 treatment techniques were screened.They mostly were Chinese compound formula or point-application therapy. The score was between 24.857 and 34.304. Application of evaluating and screening system of country feasible TCM technology can screen and evaluate the feasible technologiesin the treatment of remission phase of bronchial asthma.
作者
李敬华
王俊文
徐丽丽
于琦
朱玲
于彤
田野
孙晓峰
李泽庚
Li Jinghua;Wang Junwen;Xu Lili;Yu Qi;Tian Ye;Yu Tong;Sun Xiaofeng;Zhu Ling;Li Zegeng(Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Anhui University of Traditional Chinese Medicine,Hefei 230012,China)
出处
《世界科学技术-中医药现代化》
CSCD
北大核心
2018年第4期558-563,共6页
Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金
国家中医药管理局中医防治重大疑难疾病能力建设项目(国中医药规财函[2014]146号):中医药重大疑难病哮喘防治能力建设
负责人:李泽庚
中国中医科学院自主课题项目(ZZ090315):中医特色诊疗技术体系及其筛选应用平台的示范研究
负责人:高宏杰
王映辉
国家自然科学基金委国家自然科学基金青年项目(81503501):基于项目反应理论和混合值差度量的中医个体化诊疗疗效评价方法研究
负责人:王俊文
关键词
支气管哮喘
缓解期
治疗技术
中医药适宜技术
技术筛选
技术评估
Bronchial asthma
remission phase
treatment technology
TCM feasible technology
technology screening
technology evaluation